SCHNECK MEDICAL CENTER — History
CCN 150065 | 3-year financial timeline | COVID resilience: 37/100
🛡️ Public data only — no PHI permitted on this instance.
$184M
Latest Revenue (FY2022)
+5.9%
Revenue CAGR (3yr)
-0.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $164M | $188M | $184M | -2.0% | +5.9% |
| Operating Expenses | $162M | $170M | $186M | +9.5% | +7.1% |
| Operating Margin | 1.4% | 9.7% | -0.8% | -108.7% | +0.0% |
| Net Income | $2M | $18M | $-2M | -108.6% | +0.0% |
| Licensed Beds | 85 | 81 | 60 | -25.9% | -16.0% |
| Total Patient Days | 10,795 | 11,405 | 10,336 | -9.4% | -2.1% |
| Medicare Day % | 29% | 21% | 20% | -5.8% | -16.4% |
| Medicaid Day % | 23% | 25% | 31% | +22.6% | +15.1% |
COVID Impact & Recovery
Resilience Score: 37/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +12.3% ($164M → $184M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+5.9%
This Hospital
+7.6%
State Avg
Latest Margin
-0.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $194M | -2.0% |
| FY2024 (proj) | $204M | -3.1% |
| FY2025 (proj) | $214M | -4.2% |